ArticleJCO precision oncology2024

Feasibility and Clinical Utility of Reporting Hereditary Cancer Predisposition Pathogenic Variants Identified in Research Germline Sequencing: A Prospective Interventional Study.

Megan L Hutchcraft et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.